229 related articles for article (PubMed ID: 30690298)
1. Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese.
Song P; Zha M; Yang X; Xu Y; Wang H; Fang Z; Yang X; Xia W; Zeng C
Atherosclerosis; 2019 Mar; 282():57-66. PubMed ID: 30690298
[TBL] [Abstract][Full Text] [Related]
2. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
[TBL] [Abstract][Full Text] [Related]
3. The prevalence, awareness, treatment and control of dyslipidemia among adults in China.
Pan L; Yang Z; Wu Y; Yin RX; Liao Y; Wang J; Gao B; Zhang L;
Atherosclerosis; 2016 May; 248():2-9. PubMed ID: 26978581
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of dyslipidemia and associated risk factors among adults aged ≥35 years in northern China: a cross-sectional study.
Xi Y; Niu L; Cao N; Bao H; Xu X; Zhu H; Yan T; Zhang N; Qiao L; Han K; Hang G; Wang W; Zhang X
BMC Public Health; 2020 Jul; 20(1):1068. PubMed ID: 32631296
[TBL] [Abstract][Full Text] [Related]
5. Awareness, treatment, control, and determinants of dyslipidemia among adults in China.
Opoku S; Gan Y; Yobo EA; Tenkorang-Twum D; Yue W; Wang Z; Lu Z
Sci Rep; 2021 May; 11(1):10056. PubMed ID: 33980884
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.
Liu X; Yu S; Mao Z; Li Y; Zhang H; Yang K; Zhang H; Liu R; Qian X; Li L; Bie R; Wang C
Lipids Health Dis; 2018 May; 17(1):119. PubMed ID: 29788966
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP).
Opoku S; Gan Y; Fu W; Chen D; Addo-Yobo E; Trofimovitch D; Yue W; Yan F; Wang Z; Lu Z
BMC Public Health; 2019 Nov; 19(1):1500. PubMed ID: 31711454
[TBL] [Abstract][Full Text] [Related]
8. Stroke Risk Factors of Stroke Patients in China: A Nationwide Community-Based Cross-Sectional Study.
Chen J; Zhu Q; Yu L; Li Y; Jia S; Zhang J
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457673
[TBL] [Abstract][Full Text] [Related]
9. [Awareness rate, treatment rate and control rate of dyslipidemia in Chinese adults, 2010].
Li JH; Wang LM; Mi SQ; Zhang M; Li YC; Jiang Y; Xu Y; Dai M; Wang LH
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Aug; 46(8):687-91. PubMed ID: 23157860
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China.
Li Y; Zhao L; Yu D; Ding G
PLoS One; 2018; 13(10):e0205709. PubMed ID: 30325950
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of dyslipidemia and associated factors among the hypertensive population from rural Northeast China.
Yu S; Yang H; Guo X; Zhang X; Zheng L; Sun Y
BMC Public Health; 2015 Nov; 15():1152. PubMed ID: 26589291
[TBL] [Abstract][Full Text] [Related]
12. The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China.
Ge P; Dong C; Ren X; Weiderpass E; Zhang C; Fan H; Zhang J; Zhang Y; Xi J
PLoS One; 2015; 10(12):e0144104. PubMed ID: 26640891
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China.
Cai L; Zhang L; Liu A; Li S; Wang P
J Atheroscler Thromb; 2012; 19(2):159-68. PubMed ID: 22041495
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and awareness of dyslipidemia among overweight and obese population in Beijing community].
Fu YY; Yu JM; Wang JH; Wang JS; Sun YH; Liu HF; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):562-6. PubMed ID: 21033142
[TBL] [Abstract][Full Text] [Related]
15. Geographic Variations in the Prevalence, Awareness, Treatment, and Control of Dyslipidemia among Chinese Adults in 2018-2019: A Cross-sectional Study.
Zhang M; Peng K; Zhang X; Liu YS; Liu XY; Han GY; Shi Y; Huang ZJ; Li C; Zhao ZP; Wang LM; Li YC
Biomed Environ Sci; 2023 Apr; 36(4):313-323. PubMed ID: 37105906
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study.
He H; Yu YQ; Li Y; Kou CG; Li B; Tao YC; Zhen Q; Wang C; Kanu JS; Huang XF; Han M; Liu YW
Lipids Health Dis; 2014 Aug; 13():122. PubMed ID: 25086650
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China.
Yan L; Xu MT; Yuan L; Chen B; Xu ZR; Guo QH; Li Q; Duan Y; Huang Fu J; Wang YJ; Zhang M; Luo ZJ; Zhao WG; Wang YM; Yuan ZF; Wang WQ; Wang PH; Ran XW; Wang YJ; Yang HZ; Gao L; Chen WQ; Ning G
J Clin Lipidol; 2016; 10(1):150-60. PubMed ID: 26892132
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, awareness, treatment, and control of hypertension in Northern China: a cross-sectional study.
Xu X; Bao H; Tian Z; Zhu H; Zhu L; Niu L; Yan T; Dong H; Fang X; Zhang X
BMC Cardiovasc Disord; 2021 Nov; 21(1):525. PubMed ID: 34736420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
